Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The objective of the trial is to demonstrate a statistically significant and clinically relevant disease free survival benefit in stage II and III PIK3CA mutated colon cancer patients taking daily adjuvant aspirin for 3 years.
Critère d'inclusion
- PIK3CA mutated colon cancer